Home > National Drug Code (NDC) > Theophylline

Theophylline - 50111-459-02 - (Theophylline)

Alphabetical Index


Drug Information of Theophylline

Product NDC: 50111-459
Proprietary Name: Theophylline
Non Proprietary Name: Theophylline
Active Ingredient(s): 300    mg/1 & nbsp;   Theophylline
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Theophylline

Product NDC: 50111-459
Labeler Name: Pliva Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA089763
Marketing Category: ANDA
Start Marketing Date: 19900930

Package Information of Theophylline

Package NDC: 50111-459-02
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (50111-459-02)

NDC Information of Theophylline

NDC Code 50111-459-02
Proprietary Name Theophylline
Package Description 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (50111-459-02)
Product NDC 50111-459
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Theophylline
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 19900930
Marketing Category Name ANDA
Labeler Name Pliva Inc.
Substance Name THEOPHYLLINE ANHYDROUS
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Methylxanthine [EPC],Xanthines [Chemical/Ingredient]

Complete Information of Theophylline


General Information